CAF-DCF Overview
- Year Founded
-
1975
- Status
-
Acquired/Merged
- Employees
-
37
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
CAF-DCF General Information
Description
Supplier of plasma-derived medicines intended to treat patients suffering from serious and often rare diseases. The company supplies a wide range of coagulation factors, immunoglobulins, and certain treatments in emergencies to healthcare institutions in the Benelux region, enabling patients to receive treatment in critical situations.
Contact Information
Website
www.caf-dcf.be(Operating Subsidiary)
Corporate Office
- Neder-Over-Heembeek de Tyraslaan 75
- 1120 Brussels
- Belgium
Corporate Office
- Neder-Over-Heembeek de Tyraslaan 75
- 1120 Brussels
- Belgium
CAF-DCF Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CAF-DCF Signals
CAF-DCF Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CAF-DCF FAQs
-
When was CAF-DCF founded?
CAF-DCF was founded in 1975.
-
Where is CAF-DCF headquartered?
CAF-DCF is headquartered in Brussels, Belgium.
-
What is the size of CAF-DCF?
CAF-DCF has 37 total employees.
-
What industry is CAF-DCF in?
CAF-DCF’s primary industry is Distributors (Healthcare).
-
Is CAF-DCF a private or public company?
CAF-DCF is a Private company.
-
What is CAF-DCF’s current revenue?
The current revenue for CAF-DCF is .
-
Who are CAF-DCF’s investors?
Sanquin has invested in CAF-DCF.
-
When was CAF-DCF acquired?
CAF-DCF was acquired on 08-Jul-2016.
-
Who acquired CAF-DCF?
CAF-DCF was acquired by LFB Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process